Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 110 results for "Chronic Lymphocytic Leukemia (CLL)".

Thumbnail for Deep Remission, Delayed Immunity: Prospective Characterization of Normal B-Cell Reconstitution After Venetoclax Based Therapy in CLL and its Implications for Vaccination.

CLL - 880

Deep Remission, Delayed Immunity: Prospective Characterization of Normal B-Cell Reconstitution After Venetoclax Based Therapy in CLL and its Implications for Vaccination.

Chantal Saberian

Poster Presenter: Chantal Saberian

$Thumbnail for Efficacy and Safety of CAR T-Cell Therapy in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysis$

CLL - 888

Efficacy and Safety of CAR T-Cell Therapy in Relapsed/Refractory Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysis

Hira Cheema

Poster Presenter: Hira Cheema

Previous 1...9 10 11 12 13 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Fondaparinux vs Argatroban for Heparin-Induced Thrombocytopenia in Patients With Hematologic Malignancies: A Propensity-Matched Real-World Analysis

CLL - 895

Fondaparinux vs Argatroban for Heparin-Induced Thrombocytopenia in Patients With Hematologic Malignancies: A Propensity-Matched Real-World Analysis

Ahmed Abbasi

Poster Presenter: Ahmed Abbasi

Thumbnail for Real-World Outcomes of Pirtobrutinib Versus Venetoclax After Covalent BTK Inhibitor Exposure in CLL/SLL

CLL - 916

Real-World Outcomes of Pirtobrutinib Versus Venetoclax After Covalent BTK Inhibitor Exposure in CLL/SLL

Vishw Patel

Poster Presenter: Vishw Patel

Thumbnail for Non-CLL-type MBL and CHIP are Associated Precursor Conditions: Insights from Mayo Clinic's MBL Screening Cohort

CLL - 939

Non-CLL-type MBL and CHIP are Associated Precursor Conditions: Insights from Mayo Clinic's MBL Screening Cohort

Yuan Yao

Poster Presenter: Yuan Yao

Thumbnail for Peripheral Blood Inflammatory Markers as Prognostic Indicators in Chronic Lymphocytic Leukemia

CLL - 951

Peripheral Blood Inflammatory Markers as Prognostic Indicators in Chronic Lymphocytic Leukemia

Chiara Maria Rapolla

Poster Presenter: Chiara Maria Rapolla

Thumbnail for Efficacy, Safety, and Resistance in Pirtobrutinib-Treated CLL/SLL After Covalent BTK Inhibitor Failure: A Systematic Review of the BRUIN Trial Program

CLL - 963

Efficacy, Safety, and Resistance in Pirtobrutinib-Treated CLL/SLL After Covalent BTK Inhibitor Failure: A Systematic Review of the BRUIN Trial Program

Kolluri Prathyusha

Poster Presenter: Kolluri Prathyusha

Thumbnail for Cardiovascular, Bleeding, and Mortality Outcomes with Acalabrutinib vs. Zanubrutinib in Chronic Lymphocytic Leukemia: A Real-World Analysis from the Epic Cosmos Federated EHR Network

CLL - 967

Cardiovascular, Bleeding, and Mortality Outcomes with Acalabrutinib vs. Zanubrutinib in Chronic Lymphocytic Leukemia: A Real-World Analysis from the Epic Cosmos Federated EHR Network

Abat Khan

Poster Presenter: Abat Khan

Thumbnail for Trends in Mortality Associated with Leukemias and Heart Failure Among Adults Aged =25 Years in the United States, 1999-2025: A CDC WONDER Analysis

CLL - 975

Trends in Mortality Associated with Leukemias and Heart Failure Among Adults Aged =25 Years in the United States, 1999-2025: A CDC WONDER Analysis

Anusha Kalluru

Poster Presenter: Anusha Kalluru

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors